EZR and familial pancreatic carcinoma: In this study, we investigated the effect of ezrin on the motility and invasion ability of the pancreatic cancer cell line MiaPaCa-2, as well as the expression of ezrin in pancreatic duct adenocarcinoma, chronic pancreatitis and normal pancreatic tissues.